Contrast-enhanced MDCT in patients with pancreatic neuroendocrine tumours: correlation with histological findings and diagnostic performance in differentiation between tumour grades

Halfdanarson, 2008, Pancreatic neuroendocrine tumours (pNETs): incidence, prognosis and recent trend toward improved survival, Ann Oncol, 19, 1727, 10.1093/annonc/mdn351 Yao, 2008, One hundred years after ‘‘carcinoid’’: epidemiology of and prognostic factors for neuroendocrine tumours in 35,825 cases in the United States, J Clin Oncol, 26, 3063, 10.1200/JCO.2007.15.4377 Jensen, 2012, ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumour syndromes, Neuroendocrinology, 95, 98, 10.1159/000335591 Rosenberg, 2016, Resection versus expectant management of small incidentally discovered nonfunctional pancreatic neuroendocrine tumours, Surgery, 159, 302, 10.1016/j.surg.2015.10.013 Klimstra, 2010, Neuroendocrine neoplasms of the pancreas, 322 Scarpa, 2010, Pancreatic endocrine tumours: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients, Mod Pathol, 23, 824, 10.1038/modpathol.2010.58 Rindi, 2006, TNM staging of foregut (neuro)endocrine tumours: a consensus proposal including a grading system. European Neuroendocrine Tumour Society (ENETS), Virchows Arch., 449, 395, 10.1007/s00428-006-0250-1 Hill, 2009, Pancreatic neuroendocrine tumours: the impact of surgical resection on survival, Cancer, 115, 741, 10.1002/cncr.24065 Smith, 2010, Complications after pancreatectomy for neuroendocrine tumours: a national study, J Surg Res, 163, 63, 10.1016/j.jss.2010.04.017 Hackert, 2011, Enucleation in pancreatic surgery: indications, technique, and outcome compared to standard pancreatic resections, Langenbecks Arch Surg, 396, 1197, 10.1007/s00423-011-0801-z Tatsumoto, 2013, Pancreatic neuroendocrine neoplasm: correlation between computed tomography enhancement patterns and prognostic factors of surgical and endoscopic ultrasound-guided fine-needle aspiration biopsy specimens, Abdom Imaging, 38, 358, 10.1007/s00261-012-9953-8 Rossi, 2014, Radiofrequency ablation of pancreatic neuroendocrine tumours: a pilot study of feasibility, efficacy, and safety, Pancreas, 43, 938, 10.1097/MPA.0000000000000133 McAuley, 2005, Multimodality preoperative imaging of pancreatic insulinomas, Clin Radiol, 60, 1039, 10.1016/j.crad.2005.06.005 Kim, 2013, Staging accuracy of MR for pancreatic neuroendocrine tumour and imaging findings according to the tumour grade, Abdom Imaging, 38, 1106, 10.1007/s00261-013-0011-y d'Assignies, 2009, Pancreatic endocrine tumours: tumour blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors, Radiology, 250, 407, 10.1148/radiol.2501080291 Durán, 2016, Predictive prognostic value of local and distant recurrence of F-fluorodeoxyglucose positron emission tomography for pancreatic neuroendocrine tumours with reference to World Health Organization classifications (2004, 2010). Case series study, Int J Surg, 29, 176, 10.1016/j.ijsu.2016.03.069 Bergers, 2003, Tumour genesis and the angiogenic switch, Nat RevCancer, 3, 401, 10.1038/nrc1093 Marion-Audibert, 2003, Low microvessel density is an unfavorable histoprognostic factor in pancreatic endocrine tumours, Gastroenterology, 125, 1094, 10.1016/S0016-5085(03)01198-3 Takahashi, 2007, Prognostic value of tumour architecture, tumour-associated vascular characteristics, and expression of angiogenic molecules in pancreatic endocrine tumours, Clin Cancer Res, 13, 187, 10.1158/1078-0432.CCR-06-1408 Hattori, 2009, Enhancement patterns of pancreatic adenocarcinoma on conventional dynamic multidetector row CT: correlation with angiogenesis and fibrosis, World J Gastroenterol, 15, 3114, 10.3748/wjg.15.3114 Cappelli, 2015, Contrast enhancement pattern on multidetector CT predicts malignancy in pancreatic endocrine tumours, Eur Radiol, 25, 751, 10.1007/s00330-014-3485-2 Tang, 2015, Evaluating the response of gastric carcinomas to neoadjuvant chemotherapy using iodine concentration on spectral CT: a comparison with pathological regression, Clin Radiol, 70, 1198, 10.1016/j.crad.2015.06.083 Asayama, 2006, Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma, Radiology, 238, 150, 10.1148/radiol.2381041765 Bettini, 2011, Tumour size correlates with malignancy in nonfunctioning pancreatic endocrine tumour, Surgery, 150, 75, 10.1016/j.surg.2011.02.022 Bosman, 2010 Takumi, 2015, Pancreatic neuroendocrine tumours: correlation between the contrast-enhanced computed tomography features and the pathological tumour grade, Eur J Radiol, 84, 1436, 10.1016/j.ejrad.2015.05.005 Kim, 2016, Pancreatic neuroendocrine tumour (PNET): staging accuracy of MDCT and its diagnostic performance for the differentiation of PNET with uncommon CT findings from pancreatic adenocarcinoma, Eur Radiol, 26, 1338, 10.1007/s00330-015-3941-7 Luo, 2014, Pancreatic neuroendocrine tumours: correlation between MSCT features and pathological classification, Eur Radiol, 24, 2945, 10.1007/s00330-014-3317-4 Poultsides, 2012, Pancreatic neuroendocrine tumours: radiographic calcifications correlate with grade and metastasis, Ann Surg Oncol, 19, 2295, 10.1245/s10434-012-2305-7 Kawamoto, 2013, Pancreatic neuroendocrine tumour with cystlike changes: evaluation with MDCT, AJR Am J Roentgenol, 200, W283, 10.2214/AJR.12.8941 Cloyd, 2016, Neuroendocrine tumours of the pancreas: degree of cystic component predicts prognosis, Surgery, 10.1016/j.surg.2016.04.005